Literature DB >> 10600637

Molecular cloning and functional expression of bovine spleen ecto-NAD+ glycohydrolase: structural identity with human CD38.

A Augustin1, H Muller-Steffner, F Schuber.   

Abstract

Bovine spleen ecto-NAD(+) glycohydrolase, an archetypal member of the mammalian membrane-associated NAD(P)(+) glycohydrolase enzyme family (EC 3.2.2.6), displays catalytic features similar to those of CD38, i.e. a protein originally described as a lymphocyte differentiation marker involved in the metabolism of cyclic ADP-ribose and signal transduction. Using amino acid sequence information obtained from NAD(+) glycohydrolase and from a truncated and hydrosoluble form of the enzyme (hNADase) purified to homogeneity, a full-length cDNA clone was obtained. The deduced sequence indicates a protein of 278 residues with a molecular mass of 31.5 kDa. It predicts that bovine ecto-NAD(+) glycohydrolase is a type II transmembrane protein, with a very short intracellular tail. The bulk of the enzyme, which is extracellular and contains two potential N-glycosylation sites, yields the fully catalytically active hNADase which is truncated by 71 residues. Transfection of HeLa cells with the full-length cDNA resulted in the expression of the expected NAD(+) glycohydrolase, ADP-ribosyl cyclase and GDP-ribosyl cyclase activities at the surface of the cells. The bovine enzyme, which is the first 'classical' NAD(P)(+) glycohydrolase whose structure has been established, presents a particularly high sequence identity with CD38, including the presence of 10 strictly conserved cysteine residues in the ectodomain and putative catalytic residues. However, it lacks two otherwise conserved cysteine residues near its C-terminus. Thus hNADase, the truncated protein of 207 amino acids, represents the smallest functional domain endowed with all the catalytic activities of CD38/NAD(+) glycohydrolases so far identified. Altogether, our data strongly suggest that the cloned bovine spleen ecto-NAD(+) glycohydrolase is the bovine equivalent of CD38.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10600637      PMCID: PMC1220728          DOI: 10.1042/bj3450043

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Characterization of the NAD+ glycohydrolase associated with the rat liver nuclear envelope.

Authors:  M Fukishima; H Okayama; Y Takahashi; O Hayaishi
Journal:  J Biochem       Date:  1976-07       Impact factor: 3.387

2.  Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation.

Authors:  D G Jackson; J I Bell
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

3.  Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels.

Authors:  J Heukeshoven; R Dernick
Journal:  Electrophoresis       Date:  1988-01       Impact factor: 3.535

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Solubilization and comparative properties of some mammalian diphosphopyridine nucleosidases.

Authors:  N I Swislocki; M I Kalish; F I Chasalow; N O Kaplan
Journal:  J Biol Chem       Date:  1967-03-25       Impact factor: 5.157

6.  NAD+ glycohydrolase, an ecto-enzyme of calf spleen cells.

Authors:  H M Muller; C D Muller; F Schuber
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

7.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

8.  Amphipathic properties of calf spleen NAD glycohydrolase.

Authors:  F Schuber; H Muller; I Schenherr
Journal:  FEBS Lett       Date:  1980-01-14       Impact factor: 4.124

9.  Human CD38 is an authentic NAD(P)+ glycohydrolase.

Authors:  V Berthelier; J M Tixier; H Muller-Steffner; F Schuber; P Deterre
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

10.  Preparation of analogues of NAD+ as substrates for a sensitive fluorimetric assay of nucleotide pyrophosphatase.

Authors:  C D Muller; C Tarnus; F Schuber
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

View more
  6 in total

1.  Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.

Authors:  C Cakir-Kiefer; H Muller-Steffner; N Oppenheimer; F Schuber
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

2.  Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.

Authors:  T Kirchberger; G Wagner; J Xu; C Cordiglieri; P Wang; A Gasser; R Fliegert; S Bruhn; A Flügel; F E Lund; L-H Zhang; B V L Potter; A H Guse
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

3.  The CD38-independent ADP-ribosyl cyclase from mouse brain synaptosomes: a comparative study of neonate and adult brain.

Authors:  Claire Ceni; Nathalie Pochon; Michel Villaz; Hélène Muller-Steffner; Francis Schuber; Julie Baratier; Michel De Waard; Michel Ronjat; Marie-Jo Moutin
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

4.  CD38-dependent ADP-ribosyl cyclase activity in developing and adult mouse brain.

Authors:  Claire Ceni; Nathalie Pochon; Virginie Brun; Hélène Muller-Steffner; Annie Andrieux; Didier Grunwald; Francis Schuber; Michel De Waard; Frances Lund; Michel Villaz; Marie-Jo Moutin
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

5.  Unifying mechanism for Aplysia ADP-ribosyl cyclase and CD38/NAD(+) glycohydrolases.

Authors:  C Cakir-Kiefer; H Muller-Steffner; F Schuber
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

6.  Insights into the mechanism of bovine CD38/NAD+glycohydrolase from the X-ray structures of its Michaelis complex and covalently-trapped intermediates.

Authors:  Pascal F Egea; Hélène Muller-Steffner; Isabelle Kuhn; Céline Cakir-Kiefer; Norman J Oppenheimer; Robert M Stroud; Esther Kellenberger; Francis Schuber
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.